2025 annual financial data
Curanex Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was -1,068.75%.
Operating income was -4,239,076 USD and net income was -4,225,106 USD.
Operating cash flow was -10,484,452 USD.
Get free Curanex Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,239,076 USD
- Net income
- -4,225,106 USD
- Operating cash flow
- -10,484,452 USD